Exercise rehabilitation on patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Table 2 Literature feature table

Authors	Year	Preoperative/ postoperative	Type	Medication	Experimental group age, mean ± SD	Experimental group gender (male/female)	Intervention method	Duratio (hour/time)	Frequency (time/week)	Period (week)	Control group age, mean ± SD	Control group gender	Control method
Gill Arbane	2010	After surgery	NSCLC	Analgesia	65.4 ± 8.75	N/A	ST	< 0.5	2	12	62.6 ± 3.75	N/A	UC
Denise Shuk Ting Cheung	2021	Preoperative	NSCLC	N/A	61.00 ± 12.12	5/5	AE	0.5-1	2	12	58.36 ± 9.32	5/6	SM
Denise Shuk Ting Cheung	2021	Preoperative	NSCLC	N/A	61.11 ± 7.01	6/3	RT	0.5-1	2	12	58.36 ± 9.32	5/6	SM
Raquel Sebio García	2017	Preoperative	NSCLC	N/A	70.9 ± 6.1	9/1	ST	0.5-1	3-5	According to actual condition	69.4 ± 9.4	11/1	UC
Chueh-Lung Hwang	2012	Preoperative + after surgery	NSCLC	N/A	61.0 ± 6.3	5/8	HIIT	0.5-1	3	< 12	58.5 ± 8.2	7/4	UC
Marcus Jonsson	2019	Preoperative + after surgery	NSCLC	Analgesia	68.7 ± 7.4	29/25	HIIT	< 0.5	6	12	68.4 ± 8.3	18/35	N/A
Marta K. Mikkelsen	2022	Preoperative + after surgery	NSCLC	N/A	72.1 ± 1.8	19/22	XT	0.5-1	2	12	71.5 ± 1.625	17/26	UC
Maria T. Morano	2013	Preoperative	NSCLC	N/A	68.8 ± 7.3	5/7	RT	< 0.5	4	< 12	64.8 ± 8	4/8	UC
Morten Quist	2020	Preoperative	NSCLC	N/A	65.2 ± 8.2	55/55	XT	> 1	2	12	63.5 ± 8.7	52/56	UC
Anna Rutkowska	2019	Preoperative	NSCLC	N/A	59.1 ± 6.8	18/2	XT	0.5-1	5	< 12	61.3 ± 8.8	9/1	UC
Francesco Stefanelli	2013	Preoperative	NSCLC	Improve lung function	65.5 ± 7.4	N/A	RT	> 1	5	< 12	64.8 ± 7.3	N/A	UC
Rui-Chen Ma	2021	Preoperative	NSCLC	N/A	56.97 ± 7.09	13/21	AE	0.5-1	2	According to actual condition	54.91 ± 10.09	8/27	UC

NSCLC: Non-small cell lung cancer; ST: Strength training; AE: Aerobic exercise; RT: Respiratory training; HIIT: High-intensity interval training; XT: Cross training; UC: Usual care; SM: Self-management; N/A: Not applicable.